# CJ CheilJedang Corp Needs to See a Recovery in Bio Product Prices and Improved Profitability in the Food Business—Yuanta

> Yuanta Securities maintained its Buy rating and 260,000-won target price for CJ CheilJedang, saying a sustained share-price recovery depends on a recovery in biotech product prices and improved food-business profitability. The company’s third-quarter revenue excluding CJ Logistics rose 5.7% year over year to 4.23 trillion won, while operating profit increased 6.9% to 203 billion won; Yuanta forecasts fourth-quarter operating profit of 212 billion won.

- Date: 2026-11-10 · published 2026-11-11T06:14:26.542Z
- Category: market · region South Korea · magnitude low
- Page: https://feedsoft.ai/events/93047-cj-cheiljedang-corp-needs-to-see-a-recovery-in-bio-product-prices-and-improved
- Commodities: [Lysine](https://feedsoft.ai/c/LYSINE.md)

## Why it matters

A recovery in prices for the company's biotech products could improve its earnings, but the report does not specify feed-ingredient prices or a clear supply-demand change. Feed-market implications are therefore limited.

## Sources

- en.edaily.co.kr: https://en.edaily.co.kr/news/eda202611115066/

---
Data from Feedsoft AI (https://feedsoft.ai/). For information only; not investment advice.